Company announcement - No. 52/2017
Financial calendar for Zealand Pharma in 2018
Copenhagen, November 30, 2017 - Zealand Pharma A/S ("ZEAL") announces the following dates for the company's planned
financial reporting in 2018:
7
March
Full year announcement and Annual Report 2017
16 May
Interim report
for the first three months of 2018
16
August
Interim report for 1st half 2018
15 November
Interim report for the first 9
months of 2018
Zealand's Annual General Meeting will be held on April 19, 2018.
For further information, please contact:
Mats Blom, Executive Vice President and Chief Financial Officer
Tel.: +45 31 53 79 73, e-mail: mabl@zealandpharma.com
About Zealand Pharma A/S
Zealand Pharma A/S (Nasdaq Copenhagen and New York: ZEAL) ("Zealand") is a biotechnology company focused on the discovery, design
and development of innovative peptide-based medicines. Zealand has a portfolio of medicines and product candidates under license
collaborations with Sanofi and Boehringer Ingelheim as well as a pipeline of internal product candidates focusing on specialty
gastrointestinal and metabolic diseases.
Zealand is based in Copenhagen (Glostrup), Denmark. For further information about the Company's business and activities, please
visit www.zealandpharma.com or follow us on Twitter @ZealandPharma or LinkedIn.
Attachments:
http://www.globenewswire.com/NewsRoom/AttachmentNg/4dbcd952-530a-49a5-9400-3021a64a8360
